Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)	DNA Virus Infections, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, common wart, human papilloma virus infection, skin disorder, skin disorder caused by infection, viral infectious disease	Recruiting	Phase 3	2026-05-05		NCT07457918

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Allucent (US) LLC	3
Canfield Scientific Inc.	3
CMIC Co, Ltd. Japan	11
Medidata Solutions	6
Myonex LLC	3
Torii Pharmaceuticals CO., LTD	1
Veeva Systems	4
Verrica Pharmaceuticals Inc.	3

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Florida Center for Dermatology, P.A.	Saint Augustine	United States	2
Optima Research Boardman	Boardman	United States	4
Texas Dermatology	San Antonio	United States	1
The Indiana Clinical Trials Center, PC	Plainfield	United States	9